Bronchoscopy for Mucus Removal in Asthma
(FOCUS Trial)
Trial Summary
What is the purpose of this trial?
This is a single-center study that will evaluate the safety and tolerability of removal of mucus plugs by bronchoscopy in patients with asthma. This protocol will also plan for the analysis of the features of the mucus plugs removed.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications, but you cannot participate if you are currently using anticoagulant medications.
What data supports the idea that Bronchoscopy for Mucus Removal in Asthma is an effective treatment?
The available research shows that bronchoscopy, a procedure where a tube is inserted into the airways to remove mucus, can be effective in treating conditions where mucus plugs cause breathing problems. For example, one study describes a case where a patient with severe asthma improved dramatically after a similar procedure, suggesting its potential effectiveness. However, another study found that chest physiotherapy, a treatment involving physical techniques to clear mucus, was also useful in children with asthma, indicating that there are alternative treatments available. Overall, while bronchoscopy can be effective, other treatments like chest physiotherapy may also help in managing mucus-related issues in asthma.12345
What safety data exists for bronchoscopy in asthma treatment?
The safety data for bronchoscopy in asthma treatment is limited but suggests potential benefits in severe cases. One study describes improvement in a patient with status asthmaticus after bronchoalveolar lavage and rhDNase treatment. Another report highlights bronchoscopy as a rescue therapy in severe asthma cases, showing remarkable improvement in patients on mechanical ventilation. However, the role of bronchoscopy in asthma is not clearly defined, and more research is needed to establish its safety and efficacy.12678
Is therapeutic bronchoscopy for mucus removal a promising treatment for asthma?
Research Team
John Fahy, MD, MS
Principal Investigator
Professor of Medicine
Eligibility Criteria
The FOCUS trial is for adults aged 18-80 with asthma, who have a CT mucus plug score over 5 and lung function (FEV1) below 80% but above 35% of the predicted value. Participants must not have other lung conditions like COPD or recent infections, no COVID-19 in the past month, no smoking recently or heavy smoking history, and can't be on blood thinners.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Therapeutic bronchoscopy for removal of mucus plugs
Therapeutic bronchoscopy for removal of mucus plugs is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- Central airway obstruction
- Foreign body aspiration
- Massive bleeding in the airways
- Asthma with mucus plugs
- Central airway obstruction
- Foreign body aspiration
- Massive bleeding in the airways
- Asthma with mucus plugs
- Central airway obstruction
- Foreign body aspiration
- Massive bleeding in the airways
- Asthma with mucus plugs
- Central airway obstruction
- Foreign body aspiration
- Massive bleeding in the airways
- Asthma with mucus plugs
- Central airway obstruction
- Foreign body aspiration
- Massive bleeding in the airways
- Asthma with mucus plugs
- Central airway obstruction
- Foreign body aspiration
- Massive bleeding in the airways
- Asthma with mucus plugs
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator